Castellaro et al. have demonstrated that by activating the NF-κB/STAT3/ERK cascade, an association between breast cancer cells and macrophages stimulates tamoxifen and ICI 182,780 resistance [71]. Here, NFKB1 is linked to breast carcinoma.